JFL Life Sciences Limited (NSE:JFLLIFE)
India · Delayed Price · Currency is INR 12.55
-0.65 (-4.92%)
At close: Aug 17, 2026
JFL Life Sciences Market Cap
JFL Life Sciences has a market cap or net worth of 414.09 million as of August 18, 2026. Its market cap has decreased by -7.38% in one year.
Market Cap
414.09M
Enterprise Value
616.76M
Revenue
1.31B
Ranking
n/a
PE Ratio
6.13
Stock Price
12.55
ChartMarket Cap Chart
Since September 8, 2022, JFL Life Sciences's market cap has decreased from 731.40M to 414.09M, a decrease of -43.38%. That is a compound annual growth rate of -13.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 414.09M | 0.40% |
| Dec 31, 2025 | 412.44M | -59.35% |
| Dec 30, 2024 | 1.01B | 122.29% |
| Dec 29, 2023 | 456.44M | 22.06% |
| Dec 30, 2022 | 373.95M | -48.87% |
| Sep 8, 2022 | 731.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biofil Chemicals and Pharmaceuticals | 531.18M |
| Phaarmasia | 525.74M |
| Mangalam Drugs & Organics | 450.31M |
| Parmax Pharma | 440.54M |
| Shelter Pharma | 424.29M |
| Vista Pharmaceuticals | 424.09M |
| Rajnish Wellness | 416.29M |
| ANG Lifesciences India | 410.29M |